search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Introduction and effects of structured drug counselling in the hospital.


- candidate number2259
- NTR NumberNTR777
- ISRCTNaanpassingen ISRCTN04371570
- Date ISRCTN created28-dec-2006
- date ISRCTN requested18-dec-2006
- Date Registered NTR22-sep-2006
- Secondary IDsN/A 
- Public TitleIntroduction and effects of structured drug counselling in the hospital.
- Scientific TitleIntroduction and effects of structured drug counselling in the hospital.
- ACRONYMIntroduction and effects of structural information about medicines: the patient as a guard for his medication safety
- hypothesisThe intervention lead to:
1. More knowledge about (the use of) prescribed medicines;
2. A better use of medicines during the stay in the hospital and after discharge.
- Healt Condition(s) or Problem(s) studiedCancer, Lung disease, Drug counselling
- Inclusion criteria1. Admission at one of the participating departments;
2. Informed consent;
3. Duration of admission at least 3 days maximally a month.
- Exclusion criteria1. Patients younger than 18 years;
2. Patients who are emotionally or physically not capable to participate;
3. Senile dementia, confusion of the patient;
4. Inability to express in Dutch language.
- mec approval receivedyes
- multicenter trialno
- randomisedno
- groupParallel
- Type[default]
- Studytypeintervention
- planned startdate 2-okt-2006
- planned closingdate1-jun-2007
- Target number of participants240
- Interventions1. Personalized computer generateed medications reminder charts during admission and discharge and brochures about specific medicines;
2. Patient safety chart with instructions for safe and correct use of medicines.
The intervention measurements at the departments of lung diseases and oncology lasts three months. The control measeruments lasts three months (same departments).
- Primary outcome1. Difference in knowledge about prescribed medicines between intervention and control group at measurement II, per patient corrected for the basis at measurement I (method: questionnaires);
2. Differences in correct use of medicines between intervention and control group at measurement III (method: questionnaires).
- Secondary outcome1. Differences in spotting and reporting medication deviations during the distribution of medicines in hospital between intervention and control group (measurement II);
2. Differences in satisfaction about the received information about medicines (measurement II).
- TimepointsN/A
- Trial web siteN/A
- statusinclusion stopped: follow-up
- CONTACT FOR PUBLIC QUERIESPhD. F.A.G. Hout
- CONTACT for SCIENTIFIC QUERIESPhD. C. Wagner
- Sponsor/Initiator VU University Medical Center, Nederlands instituut voor onderzoek van de gezondheidszorg (NIVEL)
- Funding
(Source(s) of Monetary or Material Support)
Agis Health Insurance , Orde van Medisch Specialisten
- PublicationsN/A
- Brief summaryAdditional information design:
3 measurements at the departments of lung diseases and oncology during intervention period as well as control period.
Measurement I: 1-3 days after admission.
Meaurement II: during discharge.
Measurement III: during re-admission or control visit.
Size of the 4 groups: 60 patients per department and apart for intervention en control (power calculation).
- Main changes (audit trail)
- RECORD22-sep-2006 - 1-dec-2009


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl